À propos
Actions
Données et outils
Évenements
Actualités
news-year-end-dec2022

Bonne année de la part de la Fédération mondiale de l’hémophilie !

L’année 2022 a été remarquable pour les personnes atteintes de troubles héréditaires de la coagulation dans le monde entier. En dépit des défis durables liés à la pandémie de COVID 19, nous avons tous continué à œuvrer pour tenter de faire de notre mission d’un Traitement pour tous une réalité.

Aussi disponible en : English Español

Nous souhaitons saluer tous nos bénévoles, les membres des Conseils d’administration de la FMH et de la FMH USA, les organisations nationales membres (ONM), les professionnels de santé, le personnel et les membres des communautés du monde entier pour leur dévouement sans faille. Sans eux, nous n’aurions pas été en mesure de soutenir la communauté mondiale des troubles de la coagulation comme nous l’avons fait. Sans eux, des événements comme le Congrès mondial 2022 de la FMH, la Journée mondiale de l’hémophilie, le Sommet mondial 2022 de la FMH sur les politiques et l’accès aux traitements et la Table ronde de la FMH sur la thérapie génique n’auraient pas pu avoir lieu.

Nous avons hâte de découvrir les nouvelles possibilités qu’offrira 2023 et sommes impatients d’accueillir des participants du monde entier à Buenos Aires pour le Sommet sur les soins intégrés 2023 de la FMH !

Pour regarder notre vidéo du Nouvel An, veuillez cliquer ici.

Au nom de la FMH, bonne année !

We’ve accomplished a lot this year, we need your help to continue strong.

Would you like to read more about similar articles?

Disclaimer

The information on the WFH website is provided for general information purposes only. The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

While every effort has been made to ensure the accuracy of the information on this site, the WFH does not guarantee the information is accurate, and is not responsible in any way whatsoever for damages arising out of the use of this website or any of the information contained herein.

Messages posted to WFH discussion forums, Facebook, Twitter, and other social media platforms do not represent the opinions of the World Federation of Hemophilia, its staff, or Board of Directors. The author of a message is solely responsibility for its content. Information posted on WFH social networks and platforms should never be a substitute for individualized professional medical advice, even when the author has medical qualifications or is considered an authority. Information posted to a discussion group should not be used to diagnose or treat a specific health problem without consulting a qualified healthcare professional. The WFH recommends that you contact your physician or local treatment centre if you have any individual questions or concerns.

References and links to other websites or references to other organizations, products, services, or publications do not constitute endorsement or approval by the WFH. The WFH is not responsible and assumes no liability for the content of any linked websites.

Fraud Alert

Unauthorized solicitations – Warning

The WFH has been made aware of various correspondences—circulated via e-mail and telephone—coming from individuals impersonating WFH staff or falsely stating that they are associated with the WFH. These correspondences, which may seek to obtain money using the name of someone affiliated with the WFH, are fraudulent and come from outside of our organization.

If you receive a suspicious solicitation, exercise extreme caution. In the case of an email, look at the email address to see if it looks suspicious (for example, all WFH emails come from @wfh.org).

We are asking you to remain vigilant, and if you have any doubts about the correspondence, please forward the email to the WFH at [email protected] or call +1 514-875-7944.